FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, particularly to magnetic nanoparticles for treating and/or preventing cancer, prepared of ferric oxides or pure iron containing an oxide-containing layer, wherein at least one therapeutically active substance is bound to said particles. Releasing at least one therapeutically active substance is caused or initiated, or accelerated substantially by a variable magnetic field.
EFFECT: group of inventions provides reducing the uncontrolled release of the therapeutically active substances during nanoparticle delivery to cancer cells.
13 cl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR HEPSIN MODULATION OF MACROPHAGE-STIMULATING PROTEIN | 2010 |
|
RU2539772C2 |
| SPARC-BINDING PEPTIDES AND USING THEM | 2009 |
|
RU2491085C2 |
| NUCLEIC ACID OF FORMULA (I): GXG OR (II): GXG, DESIGNED TO BE USED FIRST OF ALL AS IMMUNOGEN/ADJUVANT | 2007 |
|
RU2487938C2 |
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS OF TREATING TUMORS | 2019 |
|
RU2810906C2 |
| CONDITIONALLY ACTIVE POLYPEPTIDES | 2016 |
|
RU2735023C2 |
| IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY | 2013 |
|
RU2644686C2 |
| METHODS AND COMPOSITIONS FOR ACTIVATION MODULATION OF HEPATOCYTE GROWTH FACTOR | 2005 |
|
RU2405041C2 |
| METHODS OF TREATING CANCER | 2013 |
|
RU2657749C2 |
| DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
